Investigating chronic hepatitis B virus infection in China: risk factors and disease burden
This study investigates risk factors and disease burden associated with chronic hepatitis B virus (HBV) infection in a large prospective cohort study of 0.5 million adults from 10 geographically diverse areas in China, called the China Kadoorie Biobank. Chronic hepatitis B remains a pressing public health issue and is coined a ‘silent epidemic’ in China, which has the largest HBV associated disease burden in the world.
Date:
8 March 2023, 14:00 (Wednesday, 8th week, Hilary 2023)
Venue:
Webinar (Microsoft Teams)
Speaker:
Dr Elizabeth Hamilton (Oxford Population Health, University of Oxford)
Organiser:
Melvin Obadha (Oxford Global Health and Care Systems Society)
Host:
Melvin Obadha (Oxford Global Health and Care Systems Society)
Part of:
Global Health DPhil Discourse
Booking required?:
Required
Booking url:
https://tinyurl.com/GHDD0323
Audience:
Public
Editor:
Melvin Obadha